lorazepam has been researched along with Obsessive-Compulsive Disorder in 11 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hyperactivity, impulsivity, and inattention improved with lorazepam, suggesting that the attention-deficit/hyperactivity disorder symptoms could be manifestations of catatonia." | 7.73 | PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. ( Ahmed, AA; Balamuth, N; Dell, ML; Elia, J; Friedman, DF; Pati, S; Zimmerman, RA, 2005) |
| " Week 2 dosage was increased, decreased, or maintained depending on response and side effects." | 6.71 | Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. ( Aboujaoude, E; Bullock, KD; Elliott, M; Franz, B; Gamel, N; Koran, LM, 2005) |
| "Catatonia is a syndrome with protean manifestations and multiple aetiologies." | 5.37 | Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. ( Jean-Baptiste, M; Mukai, Y; Two, A, 2011) |
| " Here, we report a case of the use of the benzodiazepine antagonist flumazenil before ECT to facilitate the simultaneous use of lorazepam and ECT for the treatment of co-occurring catatonia and obsessive-compulsive disorder." | 3.78 | Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration. ( Furst, BA; Kwon, GE; Makhinson, M; Shuff, MK, 2012) |
| " Hyperactivity, impulsivity, and inattention improved with lorazepam, suggesting that the attention-deficit/hyperactivity disorder symptoms could be manifestations of catatonia." | 3.73 | PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. ( Ahmed, AA; Balamuth, N; Dell, ML; Elia, J; Friedman, DF; Pati, S; Zimmerman, RA, 2005) |
| " Week 2 dosage was increased, decreased, or maintained depending on response and side effects." | 2.71 | Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. ( Aboujaoude, E; Bullock, KD; Elliott, M; Franz, B; Gamel, N; Koran, LM, 2005) |
| "Catatonia is a syndrome with protean manifestations and multiple aetiologies." | 1.37 | Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. ( Jean-Baptiste, M; Mukai, Y; Two, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Nikjoo, A | 1 |
| Wright, C | 1 |
| Kheriaty, A | 1 |
| Van Ameringen, M | 1 |
| Patterson, B | 1 |
| Mukai, Y | 1 |
| Two, A | 1 |
| Jean-Baptiste, M | 1 |
| Makhinson, M | 1 |
| Furst, BA | 1 |
| Shuff, MK | 1 |
| Kwon, GE | 1 |
| Matthews, A | 1 |
| Kirkby, KC | 1 |
| Martin, F | 1 |
| Koran, LM | 1 |
| Aboujaoude, E | 1 |
| Bullock, KD | 1 |
| Franz, B | 1 |
| Gamel, N | 1 |
| Elliott, M | 1 |
| Elia, J | 1 |
| Dell, ML | 1 |
| Friedman, DF | 1 |
| Zimmerman, RA | 1 |
| Balamuth, N | 1 |
| Ahmed, AA | 1 |
| Pati, S | 1 |
| Göder, R | 1 |
| Friege, L | 1 |
| Treskov, V | 1 |
| Grohmann, R | 1 |
| Aldenhoff, JB | 1 |
| Carmin, CN | 1 |
| Wiegartz, PS | 1 |
| Yunus, U | 1 |
| Gillock, KL | 1 |
| Dubnitskaia, EB | 1 |
| Basov, AM | 1 |
| Bodkin, JA | 1 |
| White, K | 1 |
3 trials available for lorazepam and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
The effects of single-dose lorazepam on memory and behavioural learning.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Female; Hand Disinfection; Humans; Learning; Lorazepam; Male | 2002 |
Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combin | 2005 |
[Use of phenazepam in the treatment of neurotic conditions].
Topics: Adult; Affective Symptoms; Anti-Anxiety Agents; Benzodiazepines; Chemical Phenomena; Chemistry; Clin | 1978 |
8 other studies available for lorazepam and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
A Case Report of Scrupulosity Presenting as Catatonia in a Patient With Both OCD and OCPD.
Topics: Catatonia; Depressive Disorder, Major; Female; Humans; Lorazepam; Obsessive-Compulsive Disorder | 2022 |
Topiramate augmentation in a patient with obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Citalopram; Drug Synergism; Fear; Female; Fructose; Hum | 2015 |
Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; Combined Modality Therapy; Do | 2011 |
Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration.
Topics: Adult; Benzodiazepines; Catatonia; Combined Modality Therapy; Depressive Disorder, Major; Electrocon | 2012 |
PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis.
Topics: Attention Deficit Disorder with Hyperactivity; Autoimmune Diseases; Basal Ganglia Diseases; Catatoni | 2005 |
Association of paroxetine with suicide attempt in obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Humans; Lorazepam; Male; Methotrimeprazine; Obsess | 2000 |
Treatment of late-onset OCD following basal ganglia infarct.
Topics: Aged; Basal Ganglia Cerebrovascular Disease; Cerebral Infarction; Cognitive Behavioral Therapy; Comb | 2002 |
Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient.
Topics: Adult; Anxiety Disorders; Clonazepam; Fear; Humans; Lorazepam; Male; Obsessive-Compulsive Disorder; | 1989 |